L. Adam

643 total citations
10 papers, 544 citations indexed

About

L. Adam is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, L. Adam has authored 10 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in L. Adam's work include Estrogen and related hormone effects (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). L. Adam is often cited by papers focused on Estrogen and related hormone effects (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). L. Adam collaborates with scholars based in United States, United Kingdom and Australia. L. Adam's co-authors include Rakesh Kumar, Evelyn Jaros, P J Kelly, R M Kalbag, A. D. Mendelow, A D Pearson, R.H. Perry, Lucien Israël, M Crépin and E. V. Davison and has published in prestigious journals such as Oncogene, British Journal of Cancer and Annals of Oncology.

In The Last Decade

L. Adam

10 papers receiving 532 citations

Peers

Countries citing papers authored by L. Adam

Since Specialization

Citations

This map shows the geographic impact of L. Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Adam more than expected).

Fields of papers citing papers by L. Adam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Adam. The network helps show where L. Adam may publish in the future.

Co-authorship network of co-authors of L. Adam

This figure shows the co-authorship network connecting the top 25 collaborators of L. Adam. A scholar is included among the top collaborators of L. Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Adam. L. Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer 2017 ·Annals of Oncology ·Michael J. Overman, L. Adam, Kanwal Raghav, (unknown), Bryan K. Kee, David R. Fogelman, Cathy Eng, Eduardo Vilar, Rachna T. Shroff, Arvind Dasari, Robert A. Wolff, Jeffrey S. Morris, Enusha Karunasena, Thomas R. Pisanic, Nilofer S. Azad, Scott Kopetz	41
2	Loss of AP-2α results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo 2007 ·Oncogene ·Betty Schwartz, Vladislava O. Melnikova, Carmen S. Tellez, (unknown), (unknown), (unknown), Marya F. McCarty, L. Adam, Menashe Bar‐Eli	65
3	206 POSTER EGFR and PDGFR crosstalk may dictate the resistance to EGFR therapy in bladder cancer 2006 ·European Journal of Cancer Supplements ·L. Adam, (unknown), Gina Brown, Melissa Munsell, Wassim Kassouf, Pantelis Nicola, Colin P. Dinney, David J. McConkey, (unknown)	2
4	Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells 2002 ·Molecular and Cellular Endocrinology ·Ran Song, Richard J. Santen, Rakesh Kumar, L. Adam, Meei Huey Jeng, Shigeru Masamura, Wei Yue	33
5	Apoptosis in mammary gland and cancer. 2000 ·Endocrine Related Cancer ·Rakesh Kumar, (unknown), L. Adam	85
6	Heregulin regulation of autocrine motility factor expression in human tumor cells. 2000 ·PubMed ·Amjad H. Talukder, L. Adam, A. Raz, Rakesh Kumar	19
7	Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination. 1997 ·PubMed ·L. Adam, M Crépin, Lucien Israël	36
8	Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours 1992 ·British Journal of Cancer ·Evelyn Jaros, R.H. Perry, L. Adam, P J Kelly, (unknown), R M Kalbag, A. D. Mendelow, (unknown), A D Pearson	225
9	Cytogenetic analysis of a congenital fibrosarcoma 1991 ·Cancer Genetics and Cytogenetics ·L. Adam, E. V. Davison, Archie J. Malcolm, Andrew D.J. Pearson, Alan Craft	28
10	Cytogenetic analysis of a granulocytic sarcoma in a patient without systemic leukaemia. 1991 ·Journal of Clinical Pathology ·L. Adam, Bill Angus, Peter Carey, E. V. Davison	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact